FDA Drug Application (021629) for APIDRA SOLOSTAR by SANOFI AVENTIS US

Back to FDA Applications sponsored by SANOFI AVENTIS US

Application Number021629
Product Number003
FormINJECTABLE;SUBCUTANEOUS
Dosage300 UNITS/3ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameAPIDRA SOLOSTAR
Active IngredientINSULIN GLULISINE RECOMBINANT

Active IngredientCount
List of drugs with Active Ingredient INSULIN GLULISINE RECOMBINANT2


Back to FDA Applications sponsored by SANOFI AVENTIS US